Product
SIM0501
Aliases
SIM0501 Tablets
1 clinical trial
1 indication
Indication
CancerClinical trial
A Phase I First-in-human, Open-label Trial to Investigate the Safety, Pharmacokinetics and Antitumor Activity of SIM0501 as Monotherapy and in Combination in Participants With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2026-06-30